Evidence map›Paper›PMID 26316070›Full record

ArticleThe Journal of investigative dermatology2015

Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells.

Elisabetta Damiani, Nahum Puebla-Osorio, Enrique Gorbea, Stephen E Ullrich

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The Immunogenetics of Melanoma.Advances in experimental medicine and biology · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Are Mast Cells MASTers in Cancer?Frontiers in immunology · 2017
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Elisabetta Damiani *Dipartimento di Scienze delle Vita e dell'Ambiente, Università Politecnica delle Marche, Ancona, Italy.
Nahum Puebla-Osorio *Department of Immunology and The Center for Cancer Immunology Research, The University of Texas, MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Enrique GorbeaDepartment of Immunology and The Center for Cancer Immunology Research, The University of Texas, MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Stephen E UllrichDepartment of Immunology and The Center for Cancer Immunology Research, The University of Texas, MD Anderson Cancer Center, Houston, Texas, 77030, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Does UV-induced Unconventional Mast Cell Migration Activate Immune Suppression?R01CA131207 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ULLRICH, STEPHEN E · 2008 to 2012
$1.6M
NCI NIH HHS CA131207NCI NIH HHS CA16672NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA131207
6 · The paper itself

Abstract

UV radiation-induced systemic immune suppression is a major risk factor for skin cancer induction. The migration of dermal mast cells from the skin to the draining lymph nodes has a prominent role in activating systemic immune suppression. UV-induced keratinocyte-derived platelet-activating factor (PAF) activates mast cell migration, in part by upregulating the expression of CXCR4 on the surface of mast cells. Others have indicated that epigenetic mechanisms regulate CXCR4 expression; therefore, we asked whether PAF activates epigenetic mechanisms in mast cells. Human mast cells were treated with PAF, and the effect on DNA methylation and/or acetylation was measured. PAF suppressed the expression of DNA methyltransferase (DNMT) 1 and 3b. On the other hand, PAF increased p300 histone acetyltransferase expression, and the acetylation of histone H3, which coincided with a decreased expression of the histone deacetylase HDAC2. Chromatin immunoprecipitation assays indicated that PAF treatment activated the acetylation of the CXCR4 promoter. Finally, inhibiting histone acetylation blocked p300 upregulation and suppressed PAF-induced surface expression of CXCR4. Our findings suggest a novel molecular mechanism for PAF, activation of epigenetic modifications. We suggest that PAF may serve as an endogenous molecular mediator that links the environment (UV radiation) with the epigenome.

Indexed as

Epigenesis, GeneticAcetylationCells, CulturedDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesHumansMast CellsPlatelet Activating FactorPromoter Regions, GeneticReceptors, CXCR4CXCR4 protein, humanDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesPlatelet Activating FactorReceptors, CXCR4

Identifiers

PMID26316070
PMCPMC4648694

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.